Concepedia

Mahoko Asayama

MA

Statistics

Publications

6

Citations

305

H-Index

6

Active since

2009

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Teijin (Japan)

Mitsubishi Group (Japan)

Ono Pharmaceutical (Japan)

Mitsubishi Chemical (Japan)

Mahoko Asayama is an author at Mitsubishi Tanabe Pharma Corporation specializing in pharmacology, cardiology, and medicine.

Publications per year

2009–2017

6

Publications

6

CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia — Effects of 7 reference compounds at 10 facilities

Takashi Kitaguchi, Yuta Moriyama, Tomohiko Taniguchi et al. · Journal of Pharmacological and Toxicological Methods · 2015 · 93 citations

, , +17

Amiselimod, a novel sphingosine 1‐phosphate receptor‐1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk

Kunio Sugahara, Yasuhiro Maeda, Kyoko Shimano et al. · British Journal of Pharmacology · 2016 · 86 citations · Full text

, , +17

Removal of Sphingosine 1-Phosphate Receptor-3 (S1P<sub>3</sub>) Agonism is Essential, But Inadequate to Obtain Immunomodulating 2-Aminopropane-1,3-diol S1P<sub>1</sub> Agonists with Reduced Effect on Heart Rate

Maiko Hamada, Mitsuharu Nakamura, Masatoshi Kiuchi et al. · Journal of Medicinal Chemistry · 2010 · 41 citations · Full text

, , +11

CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes

Takashi Kitaguchi, Yuta Moriyama, Tomohiko Taniguchi et al. · Journal of Pharmacological and Toxicological Methods · 2017 · 40 citations

, , +17

Effects of an hERG Activator, ICA-105574, on Electrophysiological Properties of Canine Hearts

Mahoko Asayama, Junko Kurokawa, Kiyoshi Shirakawa et al. · Journal of Pharmacological Sciences · 2012 · 26 citations · Full text

, , +13

1–5 of 6